Correlation Between Citigroup and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Citigroup and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Citigroup and CanSino Biologics, you can compare the effects of market volatilities on Citigroup and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and CanSino Biologics.

Diversification Opportunities for Citigroup and CanSino Biologics

-0.15

Correlation Coefficient

Citigroup  CanSino Biologics

Good diversification

The 3 months correlation between Citigroup and CanSino is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Citigroup i.e., Citigroup and CanSino Biologics go up and down completely randomly.

Pair Corralation between Citigroup and CanSino Biologics

Taking into account the 90-day investment horizon Citigroup is expected to generate 2.15 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, Citigroup is 1.83 times less risky than CanSino Biologics. It trades about 0.05 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  362.00  in CanSino Biologics on December 26, 2024 and sell it today you would earn a total of  36.00  from holding CanSino Biologics or generate 9.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Citigroup  vs.  CanSino Biologics

Citigroup

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup may actually be approaching a critical reversion point that can send shares even higher in April 2025.

CanSino Biologics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Citigroup and CanSino Biologics

The main advantage of trading using opposite Citigroup and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Citigroup and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.